Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.720
-0.230 (-5.82%)
Feb 21, 2025, 4:00 PM EST - Market closed
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $127.67 million as of February 21, 2025. Its market cap has increased by 310.51% in one year.
Market Cap
127.67M
Enterprise Value
50.91M
1-Year Change
310.51%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has decreased from $140.90M to $127.67M, a decrease of -9.39%. That is a compound annual growth rate of -0.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 76.70M | -29.57% |
| Dec 31, 2024 | 108.90M | 411.27% |
| Dec 29, 2023 | 21.30M | -29.47% |
| Dec 30, 2022 | 30.20M | -60.16% |
| Dec 31, 2021 | 75.80M | -72.07% |
| Dec 31, 2020 | 271.40M | 3,292.50% |
| Dec 31, 2019 | 8.00M | -81.65% |
| Dec 31, 2018 | 43.60M | 30.15% |
| Dec 29, 2017 | 33.50M | 6.35% |
| Dec 30, 2016 | 31.50M | -87.68% |
| Dec 31, 2015 | 255.70M | 49.44% |
| Dec 31, 2014 | 171.10M | 21.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |